NICE eyes alternative payment models for cell therapies

An expert advisory group created by the U.K.'s NICE found that the committee's appraisal methods and decision framework are applicable to regenerative medicines and cell therapies, and recommended that NICE develop alternative payment methods such as a lifetime leasing model to manage and share the therapies' financial risk. The details

Read the full 505 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE